series-c-plus
Stage
2017
Founded
1
Investors
About
Omega Therapeutics develops gene control therapies using programmable epigenome editing technologies to treat diseases by modifying gene expression patterns.
Explore Omega Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.